Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 423-340-5 | CAS number: 162881-26-7 CGI 819
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Toxikokinetic information is derived as far as possible from the physico-chemical properties and available toxicity studies. Based on the reactivity of the substance at the benzoyl function, no bioaccumulation is expected.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
The substance is in solid state and is practically not soluble in water. The vapour pressure is very low and the MMAD is 22 mm. The partition coefficient of 5.8 and the molecular weight of 418 g/mol indicate a potential of uptake by the body. The substance should have a certain chemical reactivity as indicated by the skin sensitising properties. Sensitising properties of chemicals are often related to nucleophilic addition to cysteine or lysine containing proteins. In this case, benzoyl Schiff base formation was identified as a mechanism for protein binding via the model “Protein binding by OASIS” of the OECD QSAR Toolbox v2.3. As no indication of toxicity up to the limit dose was observed upon subacte dosing and very little changes in heamatology and clincial chemistry uptake occured upon subchronic dosing, systemic uptake of the substance is probably low and the absorbed fraction is rapidly detoxified by conjugation with glutathione. Conjugates are generally of higher solubility and excreted via kidney or bile.
Considering the reactivity at the benzoyl group and the absence of significant findings upon subchronic dosing, bioaccumulation of the substance is not expected.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
